The Latest News

Stay up-to-date on the latest news, ongoing insights and event information plus access a detailed archive of past events and press releases from ITS including details on collaboration and partnerships with the world’s leading pharmaceutical companies to identify specific target classes and therapeutic indications.
November 5, 2019
Innovative Targeting Solutions and Former Amgen Executive Team up to Launch A2 Biotherapeutics with a $57 Million Series A
Read More
October 21, 2019
Innovative Targeting Solutions Inc. announces the issuance of two European patents applying the HuTARG™ platform to targeted mutagenesis and the engineering of functional agonists to GPCRs
Read More
May 1, 2018
Innovative Targeting Solutions Announces Antibody Research Collaboration with Sanofi
Read More
January 22, 2018
Innovative Targeting Solutions Announces Research Agreement with Lilly
Read More
October 11, 2017
Innovative Targeting Solutions’ Collaboration with Janssen Biotech Hits Fourth Milestone
Read More
May 24, 2017
Innovative Targeting Solutions Collaboration with Janssen Biotech Achieves Multiple Milestones
Read More
April 19, 2017
Innovative Targeting Solutions Announces HuTARG™ Technology Payment from Amgen
Read More
April 19, 2017
Innovative Targeting Solutions Awarded 2017 Growth Stage Company of the Year
Read More
December 7, 2016
Innovative Targeting Solutions to Present at the 2016 Antibody Engineering and Therapeutics Annual Meeting on Novel BioSensor Display Platform
Read More
August 23, 2016
Innovative Targeting Solutions Announces Collaboration with Johnson & Johnson Innovation to Advance Drug Discovery
Read More
August 11, 2016
Zymeworks and Innovative Targeting Solutions Enter Collaboration and License Agreement to Advance Biotherapeutics Research and Development
Read More
June 7, 2016
Innovative Targeting Solutions Announces Research Collaboration with Merck
Read More
May 16, 2016
Innovative Targeting Solutions to present at Bio-International 2016
Read More
December 3, 2015
Single Variable Domain-TCRs: Innovative Targeting Solutions Inc. Introduces Novel Scaffold for T-cell Therapies.
Read More
October 5, 2015
Innovative Targeting Solutions’ HuTARG™ Protein Engineering Platform Provides Unprecedented Capabilities for the Engineering of Fully Human T-cell Receptors (TCRs)
Read More
June 2, 2015
Innovative Targeting Solutions Turns Antibody Therapeutics “Inside Out”: T-Mabs Allow for the Targeting of the Intracellular Proteome
Read More
January 5, 2015
Innovative Targeting Solutions Builds Momentum with a Key Milestone and a New Collaborator
Read More
December 4, 2014
Innovative Targeting Solutions to Present Update on GLP1R Agonist Drug Programs
Read More
September 1, 2014
Innovative Targeting Solutions GPCR Pipeline Profiled in Nature Biopharma Dealmakers
Read More
June 1, 2014
Innovative Targeting Solutions announces a breakthrough technology that generates superior human heavy chain only antibodies (HCAb)
Read More
February 19, 2014
Innovative Targeting Solutions Inc. Extends Research Collaboration with Amgen
Read More
February 18, 2014
HuTARG™ Technology Delivers High Affinity Fully Human Antibody Therapeutics
Read More
December 9, 2013
Innovative Targeting Solutions Generates the World’s First Peptide-Grafted Antibody Agonist to the G Protein-Coupled Receptor GLP1-R
Read More
December 9, 2013
HuTARG™ Technology Applied to CDR Targeted Mutagenesis for Antibody Affinity Maturation
Read More
December 1, 2012
Innovative Targeting Solutions Generates Novel anti-GPCR Therapeutics Using an Extension of the HuTARG™ Technology to Graft Functional Peptides
Read More
May 30, 2012
Innovative Targeting Solutions Closes Series A Financing
Read More
January 19, 2012
Innovative Targeting Solutions Initiates Research Collaboration
Read More
September 6, 2011
Innovative Targeting Solutions Granted U.S. Patent
Read More